Oct 23, 2023 / 01:00PM GMT
Ana Kapor - Harpoon Therapeutics Inc - IR
Good morning, everyone, and thank you for joining us for Harpoon Therapeutics ESMO 2023 webcast, where we will be discussing the data from the HPN328 program that was presented earlier today in a poster session at ESMO in Madrid, Spain. You can access the press release that was issued this past Saturday, as well as the slides that we will be reviewing by going to the Investors section of our website.
Before I turn it over to our speakers, I'd like to remind you that we will be making forward-looking statements pursuant to the Safe Harbor provisions. For risks and uncertainties associated with these statements, we refer you to Harpoon's filings with the SEC, which are available on SEC.gov or on Harpoon's website. Please be advised that today's webcast is being recorded and listeners are able to submit questions through a chat feature. After the speakers' presentation, there will be a question and answer session.
Joining me today are Julie Eastland, our Chief Executive Officer, and Dr. Luke Walker, our Chief Medical Officer. Our interim CFO, [Mike
Harpoon Therapeutics Inc ESMO 2023 Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers